Caribou Biosciences, Inc. (CRBU) Misses Q1 EPS by 6c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q1 EPS of ($0.46), $0.06 worse than the analyst estimate of ($0.40). Revenue for the quarter came in at $2.43 million versus the consensus estimate of $2.9 million.

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• SLM (SLM) Misses Q2 EPS by 16c; offers guidance
• Summit Therapeutics (SMMT) Reports In-Line Q2 EPS
• BayCom Corp (BCML) Misses Q2 EPS by 128c